A new experimental pill called enlicitide dramatically lowered levels of low-density lipoprotein (LDL) cholesterol, often referred to as “bad” cholesterol, by as much as 60%, according to a phase three clinical trial published in The New England…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply